Business · 03/07/2019Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 11 New Drug Applications from Liebel-Flarsheim Company LLC and Others
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 11 new drug applications from multiple applicants, including Liebel-Flarsheim Company LLC, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →